×
About 208 results

ALLMedicine™ Vitamin E Deficiency Center

Research & Reviews  75 results

Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
https://clinicaltrials.gov/ct2/show/NCT04198805

Jun 13th, 2022 - Background information Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the liver and is defined by evidence of hepatic steatosis (via imaging or histology) and is not due to secondary liver fat accumulat...

Vitamin E
http://emedicine.medscape.com/article/2088716-overview

May 18th, 2022 - Reference Range Vitamin E is a fat-soluble vitamin that acts as an antioxidant and free-radical scavenger in lipophilic environments. Vitamin E requires bile for absorption, and 25% of it is absorbed orally. The vitamin is stored in adipose tissue...

Vitamin E
https://emedicine.medscape.com/article/2088716-print

May 18th, 2022 - Vitamin E is a fat-soluble vitamin that acts as an antioxidant and free-radical scavenger in lipophilic environments. Vitamin E requires bile for absorption, and 25% of it is absorbed orally. The vitamin is stored in adipose tissue, liver, and mus...

Vitamin E
https://emedicine.medscape.com/article/2088716-overview

May 18th, 2022 - Reference Range Vitamin E is a fat-soluble vitamin that acts as an antioxidant and free-radical scavenger in lipophilic environments. Vitamin E requires bile for absorption, and 25% of it is absorbed orally. The vitamin is stored in adipose tissue...

Chylomicron Retention Disease - GeneReviews® - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/n/gene/cmr/

Mar 24th, 2022 - Chylomicron retention disease (CMRD), characterized by the inability to secrete chylomicrons from the enterocytes following the ingestion of fat, typically presents in infancy with failure to thrive, diarrhea, vomiting, abdominal distention, and m...

see more →

Clinicaltrials.gov  6 results

Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
https://clinicaltrials.gov/ct2/show/NCT04198805

Jun 13th, 2022 - Background information Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the liver and is defined by evidence of hepatic steatosis (via imaging or histology) and is not due to secondary liver fat accumulat...

Functional Trunk Training in Ataxia Patients
https://clinicaltrials.gov/ct2/show/NCT04740359

Feb 5th, 2021 - Hereditary ataxias are a group of genetic diseases characterized by slow progressive gait disturbance. In addition, coordination disorders can be seen in extremities, speech and eye movements. Atrophy is common in the cerebellum. Friedreich's atax...

Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
https://clinicaltrials.gov/ct2/show/NCT03582384

May 13th, 2020 - Patients with short bowel syndrome or other forms of intestinal failure/fat malabsorption are unable to tolerate adequate oral or enteral feedings. They require that nutrition be given as enteral nutrition that is delivered by feeding tube. Often ...

Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy
https://clinicaltrials.gov/ct2/show/NCT00840112

Oct 21st, 2015 - People with long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) or mitochondrial trifunctional protein (TFP) deficiency, inherited disorders of fatty acid ß-oxidation, lack an ability to fully oxidize fatty acids for energy. Progressive peripheral ...

Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD
https://clinicaltrials.gov/ct2/show/NCT02395029

Mar 20th, 2015 - Symptoms of Peyronie's disease include penile pain and curvature of the penis that prevents penetration and/or causes erectile dysfunction (ED). It is characterized by plaques that form along the top or bottom side of the penis inside the tunica a...

see more →

News  2 results

Treatments Mitigate Certain Cases of Cerebellar Ataxia
https://www.mdedge.com/neurology/article/99267/movement-disorders/treatments-mitigate-certain-cases-cerebellar-ataxia

Apr 29th, 2015 - Most cerebellar ataxias cannot be cured, but cases that result from metabolic, hereditary, inflammatory, and immune-mediated etiologies can be treated with disease-modifying therapies, according to a review article published online ahead of print.

A Metabolomic Investigation of the Effects of Vitamin E Supplementation in Humans
https://www.medscape.com/viewarticle/780792_2

Background It is well established that nutrients interact with metabolic pathways at various levels and have multiple targets. With the increasing use of '-omic' technologies in nutritional research[1] it is now becoming possible to further explor...

see more →